Literature DB >> 29470679

Reply to correspondence by Smart and Watson.

C Ratto1.   

Abstract

Year:  2018        PMID： 29470679     DOI： 10.1007/s10151-018-1763-8

Source DB:  PubMed          Journal:  Tech Coloproctol        ISSN： 1123-6337            Impact factor:   3.781


× No keyword cloud information.
  6 in total

1.  Hemorrhoids and the recurrent attempts to destroy them.

Authors:  Carlo Ratto
Journal:  Tech Coloproctol       Date:  2016-12-20       Impact factor: 3.781

2.  Cost-effectiveness of New Surgical Treatments for Hemorrhoidal Disease: A Multicentre Randomized Controlled Trial Comparing Transanal Doppler-guided Hemorrhoidal Artery Ligation With Mucopexy and Circular Stapled Hemorrhoidopexy.

Authors:  Paul A Lehur; Anne S Didnée; Jean-Luc Faucheron; Guillaume Meurette; Philippe Zerbib; Laurent Siproudhis; Béatrice Vinson-Bonnet; Anne Dubois; Christine Casa; Jean-Benoit Hardouin; Isabelle Durand-Zaleski
Journal:  Ann Surg       Date:  2016-11       Impact factor: 12.969

3.  A single-centre study on 1000 consecutive cases of transanal haemorrhoidal dearterialization.

Authors:  N J Smart; A Watson
Journal:  Tech Coloproctol       Date:  2017-12-28       Impact factor: 3.781

4.  Doppler-guided haemorrhoidal artery ligation with suture mucopexy compared with suture mucopexy alone for the treatment of Grade III haemorrhoids: a prospective randomized controlled trial.

Authors:  F Aigner; I Kronberger; M Oberwalder; A Loizides; H Ulmer; L Gruber; J Pratschke; S Peer; H Gruber
Journal:  Colorectal Dis       Date:  2016-07       Impact factor: 3.788

Review 5.  Transanal hemorrhoidal dearterialization (THD) for hemorrhoidal disease: a single-center study on 1000 consecutive cases and a review of the literature.

Authors:  Carlo Ratto; Paola Campennì; Francesco Papeo; Lorenza Donisi; Francesco Litta; Angelo Parello
Journal:  Tech Coloproctol       Date:  2017-11-24       Impact factor: 3.781

6.  Haemorrhoidal artery ligation versus rubber band ligation for the management of symptomatic second-degree and third-degree haemorrhoids (HubBLe): a multicentre, open-label, randomised controlled trial.

Authors:  Steven R Brown; James P Tiernan; Angus J M Watson; Katie Biggs; Neil Shephard; Allan J Wailoo; Mike Bradburn; Abualbishr Alshreef; Daniel Hind
Journal:  Lancet       Date:  2016-05-25       Impact factor: 79.321
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.